Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · BILL · 117th Congress · H.R. 9525 (Introduced in House) — Making continuing appropriations for fiscal year 2023, extending various health programs, and for other purposes. · Sec. 408

Sec. 408. Reauthorization of reporting requirements related to pending generic drug applications and priority review applications

33 words·~1 min read·/bill/117/hr/9525/ih/section-408·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 807 of the FDA Reauthorization Act of 2017 ( Public Law 115–52 ) is amended, in the matter preceding paragraph (1), by striking December 16, 2022 and inserting February 3, 2023 .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 408
Reauthorization of reporting requirements related to pending generic drug applications and priority review applications
Pub. L.Public Law 115-52
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.